Molecular Mechanisms of Type 2 Diabetes Mellitus

PHASE4CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

July 31, 2006

Study Completion Date

November 30, 2008

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Pioglitazone

pioglitazone, 45 mg daily

Trial Locations (1)

78229

The University of Texas Health Science Center at San Antonio, San Antonio

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Takeda

INDUSTRY

lead

The University of Texas Health Science Center at San Antonio

OTHER